TREATMENT USE AND OVERALL SURVIVAL OF PATIENTS WITH UNRESECTABLE/METASTATIC MELANOMA IN COLOMBIA: A REAL WORLD STUDY

被引：0
|
作者：
Reyes, Sanchez J. M. [1 ]
Bolanos-Lopez, J. [2 ]
Bello, C. [2 ]
Rubio, A. C. [3 ]
Gonzalez, F. J. [2 ]
Toro, A. [2 ]
Chen, K. [4 ]
Arciniegas, J. [3 ]
Alarcon, B. A. [3 ]
Garcia, M. [1 ]
机构：
[1] Pfizer SAS, Bogota, Colombia
[2] Ctr Biociencias Sura, Medellin, Colombia
[3] Pfizer SAS, Bogota, Colombia
[4] Acaster Lloyd Consulting Ltd, Cambridge, MA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO146
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [31] Overall survival in patients with metastatic melanoma treated with concurrent ipilimumab and radiotherapy
    Koller, Kristian Michael
    Mackley, Heath B.
    Wagner, Henry
    Talamo, Giampaolo
    Schell, Todd
    Pameijer, Colette
    Neves, Rogerio Izar
    Anderson, Bryan
    Kokolus, Kathleen M.
    Mallon, Carol
    Drabick, Joseph J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [32] PFS as a surrogate for overall survival in metastatic melanoma
    Kim, Kevin B.
    LANCET ONCOLOGY, 2014, 15 (03): : 246 - 248
  • [33] REAL-WORLD TREATMENT PATTERNS OF SYSTEMATIC COMBINATION THERAPY IN PATIENTS WITH METASTATIC MELANOMA
    Qiu, Y.
    Li, Z.
    Tang, F.
    Atanasov, P.
    Mahmood, S.
    Grzegorzewski, K.
    Li, Chen
    Chen, J.
    VALUE IN HEALTH, 2017, 20 (05) : A129 - A129
  • [34] FDA Approval Summary: Pembrolizumab for the Treatment of Patients with Unresectable or Metastatic Melanoma
    Barone, Amy
    Hazarika, Maitreyee
    Theoret, Marc R.
    Mishra-Kalyani, Pallavi
    Chen, Huanyu
    He, Kun
    Sridhara, Rajeshwari
    Subramaniam, Sriram
    Pfuma, Elimika
    Wang, Yaning
    Li, Hongshan
    Zhao, Hong
    Zirkelbach, Jeanne Fourie
    Keegan, Patricia
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2017, 23 (19) : 5661 - 5665
  • [35] SURVIVAL OF PATIENTS WITH ADVANCED MELANOMA IN A REAL WORLD SETTING
    Malinowski, F. J.
    McGuire, M.
    Wolthoff, P.
    Macahilig, C. P.
    Bennett, K.
    Wong, S. L.
    Penrod, J. R.
    VALUE IN HEALTH, 2013, 16 (03) : A129 - A129
  • [36] Nivolumab + relatlimab for the treatment of unresectable or metastatic melanoma
    Kosela-Paterczyk, Hanna
    Rutkowski, Piotr
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (09) : 993 - 993
  • [37] Baseline clinical and imaging predictors of treatment response and overall survival of patients with metastatic melanoma undergoing immunotherapy
    Schraag, Amadeus
    Klumpp, Bernhard
    Afat, Saif
    Gatidis, Sergios
    Nikolaou, Konstantin
    Eigentler, Thomas K.
    Othman, Ahmed E.
    EUROPEAN JOURNAL OF RADIOLOGY, 2019, 121
  • [38] Statin use is associated with improved overall survival in patients with melanoma
    Madison, Cecelia J.
    Heinrich, Michael C.
    Thompson, Reid F.
    Yu, Wesley Y.
    MELANOMA RESEARCH, 2022, 32 (04) : 291 - 294
  • [39] Using real world data to evaluate overall survival in PD1-treated vs. standard of care metastatic melanoma patients.
    Dev-Vartak, Purvi
    Yu, Xinyan
    Liu, Fa-Qiang
    Cariola, Paul
    Hodge, Jeffrey
    Gopalakrishnan, Vijayavarman
    Wade, Rolin L.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [40] Recent advances in therapeutic strategies for unresectable or metastatic melanoma and real-world data in Japan
    Hisashi Uhara
    International Journal of Clinical Oncology, 2019, 24 : 1508 - 1514
12345